Hepatic fibrosis, inflammation, and steatosis: Influence on the MR viscoelastic and diffusion parameters in patients with chronic liver disease

Radiology

Volumn 283, Issue 1, 2017, Pages 98-107

  Leitão, Helena S ^a   Doblas, Sabrina ^a   Garteiser, Philippe ^a   d'Assignies, Gaspard ^a   Paradis, Valérie ^a   Mouri, Feryel ^a   Geraldes, Carlos F G C ^a   Ronot, Maxime ^a   Van Beers, Bernard E ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC LIVER DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DISEASE ASSOCIATION; FATTY LIVER; FEMALE; HEPATITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LIVER BIOPSY; LIVER FIBROSIS; MAGNETIC RESONANCE ELASTOGRAPHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; OBUCHOWSKI SCORE; PROSPECTIVE STUDY; RADIOLOGICAL PARAMETERS; SCORING SYSTEM; SHEAR MODULUS; THREE DIMENSIONAL IMAGING; VISCOELASTICITY; CHRONIC DISEASE; DIAGNOSTIC IMAGING; ELASTOGRAPHY; INFLAMMATION; LIVER; LIVER CIRRHOSIS; LIVER DISEASE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; CHRONIC DISEASE; DIFFUSION MAGNETIC RESONANCE IMAGING; ELASTICITY IMAGING TECHNIQUES; FATTY LIVER; FEMALE; HUMANS; INFLAMMATION; LIVER; LIVER CIRRHOSIS; LIVER DISEASES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 85017141373     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2016151570     Document Type: Article

References (37)

1. Younossi ZM, Stepanova M, Afendy M, et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 2011;9(6):524-530. e1; quiz e60.
2. Ratziu V, Cadranel JF, Serfaty L, et al. A survey of patterns of practice and perception of NAFLD in a large sample of practicing gastroenterologists in France. J Hepatol 2012; 57(2):376-383.
3. Poynard T, Lenaour G, Vaillant JC, et al. Liver biopsy analysis has a low level of performance for diagnosis of intermediate stages of fibrosis. Clin Gastroenterol Hepatol 2012; 10(6):657-63.e7.
4. Taouli B, Chouli M, Martin AJ, Qayyum A, Coakley FV, Vilgrain V. Chronic hepatitis: role of diffusion-weighted imaging and diffusion tensor imaging for the diagnosis of liver fibrosis and inflammation. J Magn Reson Imaging 2008;28(1):89-95.
5. Luciani A, Vignaud A, Cavet M, et al. Liver cirrhosis: intravoxel incoherent motion MR imaging-pilot study. Radiology 2008;249(3): 891-899.
6. Bonekamp S, Torbenson MS, Kamel IR. Diffusion-weighted magnetic resonance imaging for the staging of liver fibrosis. J Clin Gastroenterol 2011;45(10):885-892.
7. Huwart L, Sempoux C, Vicaut E, et al. Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology 2008;135(1):32-40.
8. Yin M, Talwalkar JA, Glaser KJ, et al. Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol 2007;5(10):1207-1213.e2.
9. Deffieux T, Gennisson JL, Bousquet L, et al. Investigating liver stiffness and viscosity for fibrosis, steatosis and activity staging using shear wave elastography. J Hepatol 2015; 62(2):317-324.
10. Wang Y, Ganger DR, Levitsky J, et al. Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imaging. AJR Am J Roentgenol 2011;196(3):553-561.
11. Wang QB, Zhu H, Liu HL, Zhang B. Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis: a meta-analysis. Hepatology 2012;56(1):239-247.
12. Shi Y, Guo Q, Xia F, et al. MR elastography for the assessment of hepatic fibrosis in patients with chronic hepatitis B infection: does histologic necroinflammation influence the measurement of hepatic stiffness? Radiology 2014;273(1): 88-98.
13. Leitão HS, Doblas S, d'Assignies G, et al. Fat deposition decreases diffusion parameters at MRI: a study in phantoms and patients with liver steatosis. Eur Radiol 2013;23(2): 461-467.
14. Salameh N, Larrat B, Abarca-Quinones J, et al. Early detection of steatohepatitis in fatty rat liver by using MR elastography. Radiology 2009;253(1):90-97.
15. Garteiser P, Doblas S, Daire JL, et al. MR elastography of liver tumours: value of viscoelastic properties for tumour characterisation. Eur Radiol 2012;22(10):2169-2177.
16. Wagner M, Doblas S, Daire JL, et al. Diffusion-weighted MR imaging for the regional characterization of liver tumors. Radiology 2012;264(2):464-472.
17. Garteiser P, Sahebjavaher RS, Ter Beek LC, et al. Rapid acquisition of multifrequency, multislice and multidirectional MR elastography data with a fractionally encoded gradient echo sequence. NMR Biomed 2013;26(10): 1326-1335.
18. Bohte AE, Garteiser P, De Niet A, et al. MR elastography of the liver: defining thresholds for detecting viscoelastic changes. Radiology 2013;269(3):768-776.
19. Le Bihan D, Turner R, MacFall JR. Effects of intravoxel incoherent motions (IVIM) in steady-state free precession (SSFP) imaging: application to molecular diffusion imaging. Magn Reson Med 1989;10(3): 324-337.
20. Doblas S, Wagner M, Leitao HS, et al. Determination of malignancy and characterization of hepatic tumor type with diffusionweighted magnetic resonance imaging: comparison of apparent diffusion coefficient and intravoxel incoherent motion-derived measurements. Invest Radiol 2013;48(10): 722-728.
21. Dyvorne HA, Galea N, Nevers T, et al. Diffusion-weighted imaging of the liver with multiple b values: effect of diffusion gradient polarity and breathing acquisition on image quality and intravoxel incoherent motion parameters-a pilot study. Radiology 2013;266(3):920-929.
22. Rousselet MC, Michalak S, Dupré F, et al. Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 2005;41(2):257-264.
23. Bedossa P, Poitou C, Veyrie N, et al. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. Hepatology 2012;56(5):1751-1759.
24. Zou KH, Tuncali K, Silverman SG. Correlation and simple linear regression. Radiology 2003;227(3):617-622.
25. Gareen IF, Gatsonis C. Primer on multiple regression models for diagnostic imaging research. Radiology 2003;229(2):305-310.
26. Lambert J, Halfon P, Penaranda G, Bedossa P, Cacoub P, Carrat F. How to measure the diagnostic accuracy of noninvasive liver fibrosis indices: the area under the ROC curve revisited. Clin Chem 2008;54(8):1372-1378.
27. Ziol M, Handra-Luca A, Kettaneh A, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005;41(1): 48-54.
28. Arena U, Vizzutti F, Corti G, et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 2008;47(2):380-384.
29. Coco B, Oliveri F, Maina AM, et al. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat 2007;14(5): 360-369
30. Chan HL, Wong GL, Choi PC, et al. Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. J Viral Hepat 2009; 16(1):36-44.
31. Fraquelli M, Rigamonti C, Casazza G, et al. Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or C. J Hepatol 2011;54(4):621-628.
32. Gaia S, Carenzi S, Barilli AL, et al. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. J Hepatol 2011;54(1):64-71.
33. Chen J, Talwalkar JA, Yin M, Glaser KJ, Sanderson SO, Ehman RL. Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology 2011;259(3):749-756.
34. Annet L, Peeters F, Abarca-Quinones J, Leclercq I, Moulin P, Van Beers BE. Assessment of diffusion-weighted MR imaging in liver fibrosis. J Magn Reson Imaging 2007;25(1):122-128.
35. Guiu B, Petit JM, Capitan V, et al. Intravoxel incoherent motion diffusion-weighted imaging in nonalcoholic fatty liver disease: a 3.0-T MR study. Radiology 2012;265(1):96-103.
36. Bedossa P, Patel K. Biopsy and noninvasive methods to assess progression of nonalcoholic fatty liver disease. Gastroenterology 2016;150(8):1811-1822.e4.
37. Chen X, Qin L, Pan D, et al. Liver diffusionweighted MR imaging: reproducibility comparison of ADC measurements obtained with multiple breath-hold, free-breathing, respiratory-triggered, and navigator-triggered techniques. Radiology 2014;271(1):113-125.